Related Experiment Videos

Gender differences in the treatment and secondary prevention of CHD at population level

Anna Kattainen1, Veikko Salomaa, Antti Jula

  • 1Department of Health and Functional Capacity, National Public Health Institute, Helsinki and Turku, Finland. anna.kattainen@ktl.fi

Scandinavian Cardiovascular Journal : SCJ
|December 15, 2005
PubMed

Insights

Secondary prevention of coronary heart disease (CHD) is suboptimal, with significant gender disparities observed in treatment and risk factor management. This population-based study highlights areas for improved care in both men and women with CHD.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary heart disease (CHD) management and secondary prevention strategies require ongoing evaluation.
  • Current knowledge regarding treatment uptake and secondary prevention measures in CHD populations is limited.
  • Understanding gender-specific differences in CHD care is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To assess the current status of treatment and secondary prevention for coronary heart disease (CHD) in a population-based sample.
  • To identify and analyze potential gender-based variations in CHD care across different age demographics.
  • To provide data for improving secondary prevention guidelines and interventions for CHD.

Main Methods:

  • A nationally representative health examination survey conducted in Finland between 2000-2001.
  • Inclusion of 300 men and 300 women diagnosed with coronary heart disease (CHD).
  • High participation rate of 88% ensuring sample representativeness.

Main Results:

  • Revascularization procedures were significantly more common in men (34%) than women (13%).
  • Antithrombotic medication use was high in both genders (76% men, 63% women).
  • While beta-blocker use was similar (two-thirds), lipid-lowering medication use was lower (one-third); men had higher smoking rates, women higher obesity and total cholesterol.

Conclusions:

  • Secondary prevention of coronary heart disease (CHD) is not meeting optimal standards.
  • Significant gender-based differences exist in the management and secondary prevention of CHD.
  • The findings underscore the need for targeted interventions to address gender disparities in CHD care.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...